By Ryan Davis ( March 11, 2013, 5:33 PM EDT) -- Myriad Genetics Inc. urged the U.S. Supreme Court on Thursday to reject a challenge to the validity of its patents on breast cancer genes, saying that isolated genes are clearly patent-eligible because they have important uses not found in naturally occurring DNA....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.